Infant Bacterial Therapeutics AB (OSTO:IBT B) Market Cap : kr1,353.88 Mil (As of Jun. 05, 2024)

View and export this data going back to 2016. Start your Free Trial

What is Infant Bacterial Therapeutics AB Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Infant Bacterial Therapeutics AB's share price for the quarter that ended in Mar. 2024 was kr80. Infant Bacterial Therapeutics AB's Shares Outstanding (EOP) for the quarter that ended in Mar. 2024 was 13.47 Mil. Therefore, Infant Bacterial Therapeutics AB's market cap for the quarter that ended in Mar. 2024 was kr1,077.71 Mil.

Infant Bacterial Therapeutics AB's quarterly market cap increased from Sep. 2023 (kr1,053.46 Mil) to Dec. 2023 (kr1,212.43 Mil) but then declined from Dec. 2023 (kr1,212.43 Mil) to Mar. 2024 (kr1,077.71 Mil).

Infant Bacterial Therapeutics AB's annual market cap declined from Dec. 2021 (kr749.91 Mil) to Dec. 2022 (kr561.31 Mil) but then increased from Dec. 2022 (kr561.31 Mil) to Dec. 2023 (kr1,212.43 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Infant Bacterial Therapeutics AB's Enterprise Value for Today is kr1,044.26 Mil.

Infant Bacterial Therapeutics AB Market Cap Historical Data

The historical data trend for Infant Bacterial Therapeutics AB's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Infant Bacterial Therapeutics AB Market Cap Chart

Infant Bacterial Therapeutics AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Market Cap

Get a 7-Day Free Trial

1,605.35

1,257.33

749.91

561.31

1,212.43

Infant Bacterial Therapeutics AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Market Cap	Get a 7-Day Free Trial															529.88	660.10	1,053.46	1,212.43	1,077.71

Competitive Comparison of Infant Bacterial Therapeutics AB's Market Cap

For the Biotechnology subindustry, Infant Bacterial Therapeutics AB's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Infant Bacterial Therapeutics AB's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Infant Bacterial Therapeutics AB's Market Cap distribution charts can be found below:

* The bar in red indicates where Infant Bacterial Therapeutics AB's Market Cap falls into.

Infant Bacterial Therapeutics AB Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Infant Bacterial Therapeutics AB's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )	=	Share Price (A: Dec. 2023 )	*	Shares Outstanding (EOP) (A: Dec. 2023 )
	=	kr90	*	13.4714
	=	kr1,212.43

Infant Bacterial Therapeutics AB's Market Cap for the quarter that ended in Mar. 2024 is calculated as

Market Cap (Q: Mar. 2024 )	=	Share Price (Q: Mar. 2024 )	*	Shares Outstanding (EOP) (Q: Mar. 2024 )
	=	kr80	*	13.4714
	=	kr1,077.71

Infant Bacterial Therapeutics AB (OSTO:IBT B) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

Infant Bacterial Therapeutics AB Market Cap Related Terms

Thank you for viewing the detailed overview of Infant Bacterial Therapeutics AB's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

Infant Bacterial Therapeutics AB (OSTO:IBT B) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Infant Bacterial Therapeutics AB (OSTO:IBT B) » Definitions » Market Cap

Comparable Companies

Traded in Other Exchanges

9IB:Germany

Address

Bryggargatan 10, Stockholm, SWE, 111 21

Website

https://www.ibtherapeutics.com

Infant Bacterial Therapeutics AB is a pharmaceutical company that develops drugs influencing the human infant microbiome, and thereby prevents or treats rare diseases affecting premature infants. It is currently developing its lead drug candidate IBP-9414, to prevent NEC and improve feeding tolerance in premature infants. IBP-9414 contains the active compound Lactobacillus reuteri, which is a human bacterial strain naturally present in breast milk. IBT is further pursuing a second rare disease program IBP-1016 for the treatment of an unmet medical need in gastroschisis, a severe disease in infants.

Infant Bacterial Therapeutics AB (OSTO:IBT B) Headlines

No Headlines